Public opinion

­CMC-Rose Institute poll gauges voter attitudes on two coasts

Friday, September 24, 2021 - 10:00am

The poll, designed by the Rose Institute and conducted by YouGov, surveyed 2,000 respondents in California and 1,675 in New York between August 30, 2021 and September 10, 2021.

Key Points: 
  • The poll, designed by the Rose Institute and conducted by YouGov, surveyed 2,000 respondents in California and 1,675 in New York between August 30, 2021 and September 10, 2021.
  • Andrew Sinclair and Ken Miller oversaw and developed the poll comparing political attitudes in California and New York states.
  • The CMC-Rose Institute Poll was sponsored and funded by the Rose Institute of State and Local Government and Claremont McKenna College.
  • The margin of error in the New York registered voter sample is 2.83, a slightly larger weight reflecting a slightly smaller group.

Awakn Life SciencesAcquires Exclusive Rights to MDMA Research from Imperial College London

Thursday, September 23, 2021 - 12:30pm

This Was the World's First Published Study Assessing MDMA-Assisted Psychotherapy as a Treatment for Addiction

Key Points: 
  • Toronto, Ontario--(Newsfile Corp. - September 23, 2021) - Awakn Life Sciences Corp., (NEO: AWKN) (OTCQB: AWKNF) (FSE: 954) (Awakn) a biotechnology company developing and delivering psychedelic therapeutics to treat addiction, announced today that it has acquired the exclusive rights to the data from the phase IIa Bristol Imperial MDMA in Alcoholism Study (BIMA) from Imperial College London, which has one of the world's leading psychedelics research centers.
  • The results which were published in February 2021, indicated that MDMA has the potential to be more effective at treating AUD.
  • This data will assist Awakn's progress by enabling a better design and more efficient execution of its clinical program.
  • Awakn will now be able to accelerate its clinical research into a phase IIb randomized controlled trial (RCT) in the U.K.

Avant Brands Enters Premium Concentrates Category with the Launch of Tenzo Vapes

Thursday, September 23, 2021 - 1:30pm

The Tenzo 510-thread vape cartridges were meticulously designed to elevate the consumer experience, using high-end hardware with a strong focus on safety and performance.

Key Points: 
  • The Tenzo 510-thread vape cartridges were meticulously designed to elevate the consumer experience, using high-end hardware with a strong focus on safety and performance.
  • "Entering into concentrates, which is the second largest consumption category, with our Tenzo vape cartridges marks a pivotal milestone as we continue to execute on our market growth strategy, said Norton Singhavon, Founder & CEO of Avant Brands.
  • Avant has recently executed multiple agreements with leading Canadian extraction companies in order to facilitate the launch of various concentrate products under the Companys recreational cannabis brands.
  • The Company anticipates that entering into the concentrates segment will enable Avant to leverage the success that it has built through its superior cannabis flower, highly sought-after brands and innovative products.

SOL Global Investments Corp. Announces Substantial Issuer Bid

Thursday, September 23, 2021 - 1:00pm

SOL Global Investments Corp. (the Company or SOL Global) (CSE: SOL) (OTCQ: SOLCF) (Frankfurt: 9SB) is pleased to announce that further to its press release dated September 7, 2021, its board of directors (the Board) has approved the launch and terms of a substantial issuer bid (the Offer) pursuant to which SOL Global will offer to purchase for cancellation up to $30,000,000 of its outstanding common shares (the Common Shares).

Key Points: 
  • SOL Global Investments Corp. (the Company or SOL Global) (CSE: SOL) (OTCQ: SOLCF) (Frankfurt: 9SB) is pleased to announce that further to its press release dated September 7, 2021, its board of directors (the Board) has approved the launch and terms of a substantial issuer bid (the Offer) pursuant to which SOL Global will offer to purchase for cancellation up to $30,000,000 of its outstanding common shares (the Common Shares).
  • As a result, SOL Global shareholders who tender their Common Shares will set the purchase price for the Offer.
  • Common Shares deposited at or below the purchase price as finally determined by SOL Global will be purchased at such purchase price.
  • About SOL Global Investments Corp.
    SOL Global is a diversified investment and private equity holding company engaged in the small and mid-cap sectors.

Numinus Completes Acquisition of Neurology Centre of Toronto

Thursday, September 23, 2021 - 2:00pm

Founded in 2017 by Dr. Evan Lewis (MD), NCT will operate as the "Neurology Centre of Toronto by Numinus" and continue under Dr. Lewis' leadership.

Key Points: 
  • Founded in 2017 by Dr. Evan Lewis (MD), NCT will operate as the "Neurology Centre of Toronto by Numinus" and continue under Dr. Lewis' leadership.
  • Dr. Lewis will assume the role of VP, Psychedelic Neurology Services at Numinus.
  • The acquisition expands Numinus' presence into Ontario, in addition to an existing clinic and research facility in British Columbia, and clinics in Quebec.
  • These developments will form the basis for NCT by Numinus to expand into a clinical neurology centre with specialization in psychedelic neurology.

Customized, Interactive, and Entertaining: New Data from BYJU’S Reveals How Parents Say Their Children Learn Best

Thursday, September 23, 2021 - 12:00pm

The report reveals parents attitudes toward at-home learning, video games, educational shows, learning approaches, and technology.

Key Points: 
  • The report reveals parents attitudes toward at-home learning, video games, educational shows, learning approaches, and technology.
  • The insights come as parents and teachers alike are strategizing how to best get students engaged as they begin another uncertain school year.
  • 78% of parents believe that advances in technology and child psychology have had a hand in improving the way todays children learn.
  • When it comes to how students learn best, its becoming evident that theres no such thing as a one size fits all approach.

Seventh Annual Advisor Authority Reveals Financial Professionals Bullish About M&A in RIA Industry

Wednesday, September 22, 2021 - 2:00pm

"Our seventh annual Advisor Authoritystudy makes it crystal clear that RIAs and financial professionals in the wirehouse and broker-dealerchannelsare more bullish about M&A than we've seen in years.

Key Points: 
  • "Our seventh annual Advisor Authoritystudy makes it crystal clear that RIAs and financial professionals in the wirehouse and broker-dealerchannelsare more bullish about M&A than we've seen in years.
  • According to Advisor Authority, roughly three-fourths of RIAs and fee-based financial professionals (73%), nearly three-fourths of wirehouse financial professionals (74%) and roughly two-thirds of BD financial professionals (65%) say that consolidation and M&A in the RIA industry will increase.
  • Only 11% of RIAs and fee-based financial professionals, 9% of wirehouse financial professionals and 15% of broker-dealer financial professionals expect M&A to negatively impact their business.
  • For additional insights on M&A in the RIA Industry, financial professionals can also download the latest infographic from the seventh annual Advisor Authority study at: https://news.nationwide.com/study-finds-financial-professionals-bullish-...
    Nationwide's seventh annual Advisor Authority study powered by the Nationwide Retirement Institute explores critical issues confronting advisors, financial professionals and individual investorsand the innovative techniques that they need to succeed in today's complex market.

Danimer Scientific and Chevron Phillips Chemical Collaborate to Develop Technology for Lower-Cost Biodegradable Polymer Manufacturing

Wednesday, September 22, 2021 - 1:00pm

Through this collaboration, Danimer will evaluate the use of CPChems loop slurry reactor design to develop a continuous reactor system in the manufacturing process for Rinnovo.

Key Points: 
  • Through this collaboration, Danimer will evaluate the use of CPChems loop slurry reactor design to develop a continuous reactor system in the manufacturing process for Rinnovo.
  • Stephen E. Croskrey, Chief Executive Officer of Danimer, said, CPChems loop slurry technology is one of the worlds most renowned processes for producing polyolefins efficiently and economically.
  • Today, the technology, through CPChem and its licensees, accounts for a significant portion of high-density polyethylene production worldwide.
  • We assume no obligation to update any forward-looking statements to reflect events or circumstances after the date of this press release.

New Survey Provides Insights Into Drinking Behaviors During the Pandemic

Wednesday, September 22, 2021 - 12:00pm

Of those surveyed whose responses met the criteria for heavy drinking, only 13% reported that they were undergoing treatment for their drinking at the time of the survey.

Key Points: 
  • Of those surveyed whose responses met the criteria for heavy drinking, only 13% reported that they were undergoing treatment for their drinking at the time of the survey.
  • This particular survey provides insight into drinking patterns, as well as respondents' help-seeking motivations and behaviors," said Craig Hopkinson, M.D., Chief Medical Officer and Executive Vice President of Research & Development at Alkermes.
  • Key findings from the survey include:
    Many survey respondents who met the criteria for heavy drinking said that, over the last 12 months, they experienced negative mental, physical and psychosocial impacts.
  • Over half (56%) of survey respondents who met the criteria for heavy drinking said that someone had expressed concern to them about their drinking.

New Survey Provides Insights Into Drinking Behaviors During the Pandemic

Wednesday, September 22, 2021 - 12:00pm

DUBLIN, Sept. 22, 2021 /PRNewswire/ -- A new online survey conducted during the COVID-19 pandemic by The Harris Poll on behalf of Alkermes, Inc., a subsidiary of Alkermes plc (Nasdaq: ALKS), found that 17% of respondents aged 21 and over reported drinking patterns that met the survey criteria for "heavy drinking"*. Of those surveyed whose responses met the criteria for heavy drinking, only 13% reported that they were undergoing treatment for their drinking at the time of the survey. The survey results also suggest that family and friends can play an important role in motivating people with heavy drinking patterns to get help. The survey is part of Alkermes' ongoing commitment to understanding the unique needs of people who may be living with a substance use disorder and supporting increased disease state awareness and education.

Key Points: 
  • Of those surveyed whose responses met the criteria for heavy drinking, only 13% reported that they were undergoing treatment for their drinking at the time of the survey.
  • This particular survey provides insight into drinking patterns, as well as respondents' help-seeking motivations and behaviors," said Craig Hopkinson, M.D., Chief Medical Officer and Executive Vice President of Research & Development at Alkermes.
  • Key findings from the survey include:
    Many survey respondents who met the criteria for heavy drinking said that, over the last 12 months, they experienced negative mental, physical and psychosocial impacts.
  • Over half (56%) of survey respondents who met the criteria for heavy drinking said that someone had expressed concern to them about their drinking.